Welcome to our dedicated page for Dss SEC filings (Ticker: DSS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking a company that patents anti-counterfeit labels and finances commercial loans can feel like reading five annual reports at once. DSS Inc’s filings weave together packaging security, biotech trials, lending portfolios, and investment gains—details investors can’t afford to miss but rarely have time to untangle.
Stock Titan solves that problem. Our AI reads every DSS Inc quarterly earnings report 10-Q filing, scans each DSS Inc insider trading Form 4 transaction, and highlights what moves markets. Instead of parsing footnotes, you’ll see plain-English callouts—IP valuation swings, biotech milestone expenses, or credit-loss reserves—delivered the moment EDGAR releases them. Looking for the next Form 4 insider transactions real-time alert? Want the DSS Inc annual report 10-K simplified to a five-minute brief? It’s already waiting on this page.
Use the navigation below to answer questions professionals ask every quarter: How did packaging security margins shift? Which executives bought shares after a new patent license? Our coverage spans:
- 8-K material events explained—patent wins, biotech data, or loan impairments
- Proxy statement executive compensation insights for DSS Inc’s diverse leadership
- Earnings report filing analysis comparing segment revenues over time
Whether you’re understanding DSS Inc SEC documents with AI for the first time or need a quick refresh before a call, this hub keeps you current, confident, and ahead of the curve.
DSS, Inc. (NYSE American: DSS) disclosed in an 8-K filed on July 1, 2025 that it dismissed Grassi & Co., CPAs, P.C. as its independent registered public accounting firm, effective June 27, 2025. The Board of Directors approved the decision and, on the same date, appointed HTL International, LLC as the new auditor.
The company states that, for the engagement period from July 1, 2022 through June 27, 2025, there were no disagreements with Grassi concerning accounting principles, financial-statement disclosures, or audit scope and procedures that would have required reference in Grassi’s reports. DSS also confirms that, during the last two fiscal years and up to the engagement date, it did not consult HTL on any accounting matters or the type of audit opinion to be rendered, and there were no reportable events under Item 304(a)(1)(v) of Regulation S-K.
Exhibit 16.1 will contain Grassi’s letter to the SEC confirming the disclosures. The change suggests a routine auditor transition rather than a reaction to a dispute, but investors may monitor the first audit cycle for any adjustments or restatements under the new firm.
FAQ
What is the current stock price of Dss (DSS)?
What is the market cap of Dss (DSS)?
What is the primary focus of DSS Inc?
How does DSS Inc protect against counterfeiting?
What are the main operating segments of DSS Inc?
How does DSS Inc generate revenue?
Which industries benefit from DSS Inc's innovations?
How does DSS Inc differentiate itself from competitors?
What role does intellectual property play in DSS Inc's strategy?
How has recent leadership transition impacted DSS Inc?
